Skip to main content

Day: November 14, 2023

View Announces Q3 2023 Earnings

MILPITAS, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) — View, Inc. (Nasdaq: VIEW) (“View” or the “Company”), a leader in smart building platforms and technologies, today announced financial results for Q3 2023. Q3 2023 Financial HighlightsRevenue Growth: Q3’23 revenue of $38 million grew 61% year-over-year compared to $24 million in Q3’22. Gross Margin Improvement: Higher quality revenue and lower fixed costs drove improving margins year-over-year:Gross Margin improved from ($25 million) in Q3’22 to ($4 million) in Q3’23, which included $6 million of charges from changes in estimated manufactured per-unit costs due to a revised future production outlook and $0.3 million of non-cash stock-based compensation expense. Gross Margin, without the future production outlook adjustments described above, was positive in Q3’23.Reduction...

Continue reading

KULR Technology Group Reports Third Quarter 2023 Financial Results; Company on Track with Analysts’ Q4 Forecasts

SAN DIEGO, Nov. 14, 2023 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a global leader in sustainable energy management, today reported results for the third quarter ended September 30, 2023. Third Quarter 2023 Financial Results Revenues: In the third quarter that ended September 30, 2023, revenue increased to $3.04 million from $1.39 million reported in the same period last year, with revenues more than doubling – or an increase of approximately 118%. Contract Services revenue increased over 4,800%, with revenue of approximately $1.14 million versus approximately $20 thousand in the same quarter last year. Product revenue for the quarter was approximately $1.90 million, up from approximately $1.37 million during the same period last year for an increase...

Continue reading

Onfolio Holdings Inc. Announces Third Quarter 2023 Financial Results and Provides Corporate Update

WILMINGTON, Del., Nov. 14, 2023 (GLOBE NEWSWIRE) — Onfolio Holdings Inc. (NASDAQ: ONFO, ONFOW) (“Onfolio” or the “Company”), a holding company that acquires and manages a diversified portfolio of online businesses across a broad range of verticals, announces financial results for the third quarter ended September 30, 2023. Financial HighlightsThird quarter 2023 revenue grew 273% year-over-year to $1.31 million compared to $0.35 million in the third quarter of 2022 Third quarter 2023 gross profit grew 526% to $0.85 million (representing gross margin of 64.5%) vs. $0.14 million in the prior year period (representing gross margin of 38.4%) Third quarter 2023 total operating expenses increased 397% to $5.59 million (including approximately $3.8 million in impairment charges related to intangible assets) vs. $1.12 million in the prior...

Continue reading

MachTen, Inc. Reports Results for the Third Quarter 2023

TRAVERSE CITY, Mich., Nov. 14, 2023 (GLOBE NEWSWIRE) — MachTen, Inc. (“MACT”) (OTC: MACT) today reported its operating results for the quarter ended September 30, 2023. “It’s an exciting time for MachTen! We completed the spin-off from LICT on August 31, and appreciate the unwavering efforts of our teams in Carney, Traverse City and Rye. While our 3rd quarter earnings reflect a strong foundation, we have very significant opportunities to improve operating efficiencies as a standalone public company with a focused management team. We are well positioned to benefit from industry trends, and have a clear plan for meaningful growth in the years ahead,” commented Dan Miller, Chief Executive Officer. Financial Highlights(In thousands)   Three Months Ended    September 30, 2023   September 30, 2022         Regulated revenue   $ 3,079   $ 3,120Non-regulated...

Continue reading

Notable Labs Announces Filing of Form 10-Q for Third Quarter 2023

-Summarizes third quarter 2023 financials of pre-Merger VBLT as of September 30th– -Third quarter financial information of Notable Labs, Inc. and pro forma combined financial information of Notable Labs, Ltd. will be subsequently provided via Form 8-K later in November- FOSTER CITY, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) — Notable Labs, Ltd. (“Notable”) (Nasdaq: NTBL), a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, today announced that it has filed its Quarterly Report on Form 10-Q containing financial results for the third quarter and nine months ended September 30, 2023. Due to the timing of the closing of Notable’s merger with VBL Therapeutics in October 2023, the Form 10-Q contains financial results of pre-merger VBL Therapeutics. In October, Notable closed...

Continue reading

Stryve Foods, Inc. Reports Third Quarter Fiscal 2023 Results

Improved Adj. EBITDA Loss by 35.0% Year-over-YearRetail Dollar Sales Growth of 21.0% Year-over-Year in Measured Channels146.8% Year-over-Year Reduction in YTD Operating Expenses Shows Transformation Progress PLANO, Texas, Nov. 14, 2023 (GLOBE NEWSWIRE) — Stryve Foods, Inc. (“Stryve” or “the Company”) (NASDAQ: SNAX), an emerging healthy snack and eating platform disrupting traditional consumer packaged goods (CPG) categories, and a leader in the air-dried meat snack industry in the United States, today reports financial and operating results for the three months and nine months ended September 30, 2023. The Company’s products in the aggregate continue to outperform the category in measured channels. The most recent 24-week SPINS data reflects meaningful year-over-year improvement in measured channels with retail dollar sales increasing...

Continue reading

Unicycive Announces Third Quarter 2023 Financial Results and Provides Business Update

Reached Alignment with the FDA on the Data Package Requirements to File NDA for oxylanthanum carbonate (OLC) OLC Pivotal Clinical Trial Expected to Initiate Before Year End LOS ALTOS, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY) (the “Company” or “Unicycive”), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced its financial results for the third quarter ended September 30, 2023, and provided a business update. “Gaining alignment with the FDA on our clinical development plan for oxylanthanum carbonate (OLC) was a major achievement as we are one step closer to potentially bringing a much-needed therapy to individuals living with chronic kidney disease on dialysis,” said Shalabh Gupta, M.D., Chief Executive Officer of Unicycive. “With...

Continue reading

Fluent Announces Third Quarter 2023 Financial Results

Revenue of $66.2 million for Q3 2023 and $225.6 million for YTD 2023 Gross profit (exclusive of depreciation and amortization) of $16.1 million for Q3 2023 and $57.7 million for YTD 2023 Net loss of $33.6 million for Q3 2023 and $61.3 million for YTD 2023 Media margin of $19.3 million for Q3 2023 and $67.2 million for YTD 2023 Adjusted EBITDA of negative $1.7 million for Q3 2023 and positive $4.3 million for YTD 2023 Adjusted net loss of $4.1 million for Q3 2023 and $6.8 million for YTD 2023NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) — Fluent, Inc. (NASDAQ: FLNT), a leading data-driven performance marketing company, today reported financial results for the third quarter ended September 30, 2023. Don Patrick, Fluent’s Chief Executive Officer, commented, “Our third quarter results clearly reflect our post-FTC settlement transition...

Continue reading

NXT Energy Solutions Announces Third Quarter 2023 Results

CALGARY, Alberta, Nov. 14, 2023 (GLOBE NEWSWIRE) — NXT Energy Solutions Inc. (“NXT” or the “Company”) (TSX: SFD; OTCQB: NSFDF) today announced the Company’s financial and operating results for the three and nine months ended September 30, 2023. All dollar amounts herein are in Canadian Dollars unless otherwise identified. Financial and Operating Highlights Key financial and operational highlights are summarized below:on September 5, 2023. NXT announced that it has executed a contract to provide an SFD® survey to an independent oil and gas exploration company in Turkiye; the second tranche of the convertible debenture with strategic partner Ataraxia Capital contributed $0.27 million of cash; cash at September 30, 2023 was $0.37 million; net working capital was ($3.47) million at September 30, 2023; the...

Continue reading

Fortress Biotech Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

Total consolidated net revenue was $34.8 million in the third quarter of 2023, a 100% increase from total consolidated net revenue of $17.4 million in the second quarter of 2023 Fortress is advancing several late-stage clinical assets with three potential NDA and BLA submissions to FDA through year-end of 2024 across our portfolio1, including a NDA submission for DFD-29 to treat rosacea, anticipated around year-end of 2023 MIAMI, Nov. 14, 2023 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates, today announced financial results and recent corporate highlights for the third quarter ended September 30, 2023. Lindsay A. Rosenwald, M.D., Fortress’...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.